This week we look at how changes to accelerated approvals at the U.S. Food and Drug Administration (FDA) are affecting the number of drugs being approved. Also this week, there is news of CVS’s brief foray into clinical trials, the end of the public health emergency for COVID-19, and the costs of the ... READ MORE >